Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Zabalza

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Journal of Neurology|January 10, 2022
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centreAlvaro Cobo-Calvo, Ana Zabalza, Jordi Río, et al.
Neuroimage. Clinical|March 20, 2023
Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRILlucia Coll, Deborah Pareto, Pere Carbonell-Mirabent, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2025
Performance of treatment response scoring systems among patients with multiple sclerosis treated with high-efficacy therapiesMariano Marrodan, Augusto Sao Avilés, Jordi Río, et al.
Journal of Neurology|February 22, 2022
Correction to: Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centreAlvaro Cobo-Calvo, Ana Zabalza, Jordi Río, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 7, 2023
Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRILlucia Coll, Deborah Pareto, Pere Carbonell-Mirabent, et al.
Multiple Sclerosis and Related Disorders|November 30, 2025
"Effectiveness and associated factors of response to Fampridine in multiple sclerosis: A prospective observational study from an expert center"Elisa Martinez-Campos, Miguel Angel Robles, Rosalia Horno, et al.
Annals of Neurology|September 14, 2023
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple SclerosisJavier Villacieros-Álvarez, Carmen Espejo, Georgina Arrambide, et al.
The Lancet Regional Health. Europe|April 28, 2025
The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational studyCarmen Tur, Pere Carbonell-Mirabent, Susana Otero-Romero, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Journal of Neurology|January 10, 2022
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centreAlvaro Cobo-Calvo, Ana Zabalza, Jordi Río, et al.
Neuroimage. Clinical|March 20, 2023
Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRILlucia Coll, Deborah Pareto, Pere Carbonell-Mirabent, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2025
Performance of treatment response scoring systems among patients with multiple sclerosis treated with high-efficacy therapiesMariano Marrodan, Augusto Sao Avilés, Jordi Río, et al.
Journal of Neurology|February 22, 2022
Correction to: Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centreAlvaro Cobo-Calvo, Ana Zabalza, Jordi Río, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 7, 2023
Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRILlucia Coll, Deborah Pareto, Pere Carbonell-Mirabent, et al.
Multiple Sclerosis and Related Disorders|November 30, 2025
"Effectiveness and associated factors of response to Fampridine in multiple sclerosis: A prospective observational study from an expert center"Elisa Martinez-Campos, Miguel Angel Robles, Rosalia Horno, et al.
Annals of Neurology|September 14, 2023
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple SclerosisJavier Villacieros-Álvarez, Carmen Espejo, Georgina Arrambide, et al.
The Lancet Regional Health. Europe|April 28, 2025
The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational studyCarmen Tur, Pere Carbonell-Mirabent, Susana Otero-Romero, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Pageof 11